1. Home
  2. VC vs HRMY Comparison

VC vs HRMY Comparison

Compare VC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VC
  • HRMY
  • Stock Information
  • Founded
  • VC 2000
  • HRMY 2017
  • Country
  • VC United States
  • HRMY United States
  • Employees
  • VC N/A
  • HRMY N/A
  • Industry
  • VC Auto Parts:O.E.M.
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • VC Consumer Discretionary
  • HRMY Health Care
  • Exchange
  • VC Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • VC 2.3B
  • HRMY 2.0B
  • IPO Year
  • VC 2000
  • HRMY 2020
  • Fundamental
  • Price
  • VC $102.88
  • HRMY $32.11
  • Analyst Decision
  • VC Buy
  • HRMY Strong Buy
  • Analyst Count
  • VC 14
  • HRMY 9
  • Target Price
  • VC $99.33
  • HRMY $54.22
  • AVG Volume (30 Days)
  • VC 427.6K
  • HRMY 624.9K
  • Earning Date
  • VC 07-24-2025
  • HRMY 08-05-2025
  • Dividend Yield
  • VC N/A
  • HRMY N/A
  • EPS Growth
  • VC N/A
  • HRMY 13.13
  • EPS
  • VC 10.69
  • HRMY 2.62
  • Revenue
  • VC $3,867,000,000.00
  • HRMY $744,852,000.00
  • Revenue This Year
  • VC N/A
  • HRMY $20.10
  • Revenue Next Year
  • VC $4.10
  • HRMY $18.01
  • P/E Ratio
  • VC $9.66
  • HRMY $12.25
  • Revenue Growth
  • VC N/A
  • HRMY 20.62
  • 52 Week Low
  • VC $65.10
  • HRMY $26.47
  • 52 Week High
  • VC $117.94
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • VC 75.88
  • HRMY 42.69
  • Support Level
  • VC $92.55
  • HRMY $31.25
  • Resistance Level
  • VC $95.63
  • HRMY $33.69
  • Average True Range (ATR)
  • VC 2.99
  • HRMY 1.03
  • MACD
  • VC 0.86
  • HRMY -0.15
  • Stochastic Oscillator
  • VC 95.72
  • HRMY 20.90

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: